HIV type 1 infection up-regulates TLR2 and TLR4 expression and function in vivo and in vitro
Toll-like receptors (TLRs) play a critical role in innate immunity against pathogens. Their stimulation induces the activation of NF-κB, an important inducer of HIV-1 replication. In recent years, an increasing number of studies using several cells types from HIV-infected patients indicate that TLRs...
Saved in:
Published in | AIDS research and human retroviruses Vol. 28; no. 10; p. 1313 |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.10.2012
|
Subjects | |
Online Access | Get more information |
ISSN | 1931-8405 |
DOI | 10.1089/aid.2011.0297 |
Cover
Loading…
Abstract | Toll-like receptors (TLRs) play a critical role in innate immunity against pathogens. Their stimulation induces the activation of NF-κB, an important inducer of HIV-1 replication. In recent years, an increasing number of studies using several cells types from HIV-infected patients indicate that TLRs play a key role in regulating the expression of proinflammatory cytokines and viral pathogenesis. In the present study, the effect of HIV-1 stimulation of monocyte-derived macrophage (MDM) and peripheral blood mononuclear cell (PBMC) subpopulations from healthy donors on the expression and functions of TLR2 and TLR4 was examined. In addition, and to complete the in vitro study, the expression pattern of TLR2 and TLR4 in 49 HIV-1-infected patients, classified according to viral load and the use of HAART, was determined and compared with 25 healthy subjects. An increase of TLR expression and production of proinflammatory cytokines were observed in MDMs and PBMCs infected with HIV-1 in vitro and in response to TLR stimulation, compared to the mock. In addition, an association between TLR expression and up-regulation of CD80 in plasmacytoid dendritic cells (pDCs) was observed. The ex vivo analysis indicated increased expression of TLR2 and TLR4 in myeloid dendritic cells (mDCs), but only of TLR2 in monocytes obtained from HIV-1-infected patients, compared to healthy subjects. Remarkably, the expression was higher in cells from patients who do not use HAART. In monocytes, there was a positive correlation between both TLRs and viral load, but not CD4(+) T cell numbers. Together, our in vitro and ex vivo results suggest that TLR expression and function can be up-regulated in response to HIV-1 infection and could affect the inflammatory response. We propose that modulation of TLRs represents a mechanism to promote HIV-1 replication or AIDS progression in HIV-1-infected patients. |
---|---|
AbstractList | Toll-like receptors (TLRs) play a critical role in innate immunity against pathogens. Their stimulation induces the activation of NF-κB, an important inducer of HIV-1 replication. In recent years, an increasing number of studies using several cells types from HIV-infected patients indicate that TLRs play a key role in regulating the expression of proinflammatory cytokines and viral pathogenesis. In the present study, the effect of HIV-1 stimulation of monocyte-derived macrophage (MDM) and peripheral blood mononuclear cell (PBMC) subpopulations from healthy donors on the expression and functions of TLR2 and TLR4 was examined. In addition, and to complete the in vitro study, the expression pattern of TLR2 and TLR4 in 49 HIV-1-infected patients, classified according to viral load and the use of HAART, was determined and compared with 25 healthy subjects. An increase of TLR expression and production of proinflammatory cytokines were observed in MDMs and PBMCs infected with HIV-1 in vitro and in response to TLR stimulation, compared to the mock. In addition, an association between TLR expression and up-regulation of CD80 in plasmacytoid dendritic cells (pDCs) was observed. The ex vivo analysis indicated increased expression of TLR2 and TLR4 in myeloid dendritic cells (mDCs), but only of TLR2 in monocytes obtained from HIV-1-infected patients, compared to healthy subjects. Remarkably, the expression was higher in cells from patients who do not use HAART. In monocytes, there was a positive correlation between both TLRs and viral load, but not CD4(+) T cell numbers. Together, our in vitro and ex vivo results suggest that TLR expression and function can be up-regulated in response to HIV-1 infection and could affect the inflammatory response. We propose that modulation of TLRs represents a mechanism to promote HIV-1 replication or AIDS progression in HIV-1-infected patients. |
Author | Stevenson, Mario Hernández, Juan C Urcuqui-Inchima, Silvio Latz, Eicke |
Author_xml | – sequence: 1 givenname: Juan C surname: Hernández fullname: Hernández, Juan C organization: Grupo Inmunovirología, Sede de Investigación Universitaria, Universidad de Antioquia, Medellín, Colombia – sequence: 2 givenname: Mario surname: Stevenson fullname: Stevenson, Mario – sequence: 3 givenname: Eicke surname: Latz fullname: Latz, Eicke – sequence: 4 givenname: Silvio surname: Urcuqui-Inchima fullname: Urcuqui-Inchima, Silvio |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22280204$$D View this record in MEDLINE/PubMed |
BookMark | eNo1T99LwzAYDKK4H_roq-QfaP3yJemSRxnqBgVBpk_CSNsvUtnS0rTD_ffSTZ_uOO6Ouxm7DE0gxu4EpAKMfXB1lSIIkQLaxQWbCitFYhToCZvF-A0AFlFfswkiGkBQU_a5Wn_w_tgSF7wOnsq-bgIf2qSjr2Hneop8k78hd6EaieL003YU4-gaNT-Ec6QO_FAfmpN44n3X3LAr73aRbv9wzt6fnzbLVZK_vqyXj3lSKg19QsU4a-GkV4CZt0ZLZyslM0LnTFEoTUZhKTBT3suFJJ85TU5gaQtJUuCc3Z9726HYU7Vtu3rvuuP2_yb-AqiwUy0 |
CitedBy_id | crossref_primary_10_1016_j_crviro_2022_100021 crossref_primary_10_1016_j_isci_2024_110131 crossref_primary_10_1002_jcp_28103 crossref_primary_10_1097_MD_0000000000023663 crossref_primary_10_1016_S2222_1808_16_61089_7 crossref_primary_10_3389_fimmu_2019_00874 crossref_primary_10_3390_cells12121565 crossref_primary_10_3390_app14177526 crossref_primary_10_2139_ssrn_2988029 crossref_primary_10_3389_fimmu_2018_02039 crossref_primary_10_3389_fimmu_2022_879600 crossref_primary_10_1016_j_jneuroim_2014_03_002 crossref_primary_10_1371_journal_pone_0119844 crossref_primary_10_1016_j_jneuroim_2018_01_015 crossref_primary_10_3390_ijms24119624 crossref_primary_10_1002_jev2_12027 crossref_primary_10_1159_000371765 crossref_primary_10_3390_biology13030146 crossref_primary_10_1007_s12026_015_8748_8 crossref_primary_10_3389_fimmu_2021_738743 crossref_primary_10_1189_jlb_4VMR0415_160R crossref_primary_10_1189_jlb_3HI0516_242R crossref_primary_10_1038_gene_2014_54 crossref_primary_10_1016_j_gene_2020_144366 crossref_primary_10_1371_journal_pone_0185162 crossref_primary_10_1007_s13365_024_01239_2 crossref_primary_10_1590_S0036_46652012000300008 crossref_primary_10_1186_s12879_023_08495_3 crossref_primary_10_3389_fimmu_2025_1541152 crossref_primary_10_1007_s12026_015_8691_8 crossref_primary_10_1089_vim_2018_0093 crossref_primary_10_1371_journal_pntd_0002060 crossref_primary_10_3389_fmicb_2020_01452 crossref_primary_10_3390_v15112206 crossref_primary_10_1128_JVI_02048_16 crossref_primary_10_3389_fimmu_2020_589010 crossref_primary_10_1155_2024_9399524 crossref_primary_10_1097_COH_0000000000000096 crossref_primary_10_1007_s13365_018_0629_1 crossref_primary_10_1099_jgv_0_000345 crossref_primary_10_4236_wja_2012_23029 crossref_primary_10_3390_v13102054 crossref_primary_10_3390_microorganisms8111787 crossref_primary_10_1007_s12026_016_8876_9 crossref_primary_10_3390_pathogens12070880 crossref_primary_10_3390_diseases3040282 crossref_primary_10_1097_QAD_0000000000000381 crossref_primary_10_3389_fcell_2021_724970 crossref_primary_10_3390_v15010052 crossref_primary_10_3390_vaccines11121861 crossref_primary_10_1016_j_semnephrol_2017_07_004 crossref_primary_10_1038_icb_2015_26 crossref_primary_10_1016_j_vaccine_2014_09_010 crossref_primary_10_3390_ijms24021465 crossref_primary_10_1172_jci_insight_145928 crossref_primary_10_1089_aid_2013_0115 crossref_primary_10_3389_fimmu_2019_01777 crossref_primary_10_1128_JVI_01767_13 crossref_primary_10_1371_journal_pone_0072789 crossref_primary_10_1371_journal_ppat_1004311 crossref_primary_10_3390_genes12010036 crossref_primary_10_1177_1753425917738331 crossref_primary_10_1016_S1473_3099_14_70917_X crossref_primary_10_3389_fimmu_2018_03092 crossref_primary_10_1189_jlb_4A1215_534R |
ContentType | Journal Article |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1089/aid.2011.0297 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1931-8405 |
ExternalDocumentID | 22280204 |
Genre | Research Support, Non-U.S. Gov't Journal Article Comparative Study |
GrantInformation_xml | – fundername: NIAID NIH HHS grantid: R01 AI083713 – fundername: NHLBI NIH HHS grantid: R01 HL112661 – fundername: NHLBI NIH HHS grantid: R01 HL093262 |
GroupedDBID | --- -~X .55 .GJ 0R~ 1CY 23M 34G 39C 4.4 53G 5GY 5RE 6J9 ABBKN ABJNI ACGFO ACGFS ACPRK ADBBV AENEX AFFNX AFRAH ALMA_UNASSIGNED_HOLDINGS BNQNF CAG CGR COF CS3 CUY CVF EBS ECM EIF EJD F5P IAO IH2 IHR IM4 INH INR ITC L7B MV1 N8Y NPM NQHIM O9- P2P RIG RML RMSOB UAP UE5 X7M ZGI |
ID | FETCH-LOGICAL-c450t-eb92257a3f4026f9853a9d436e2aa8bb45e842c1264ff373ef6a5ea12c9b3e312 |
IngestDate | Thu Apr 03 06:54:42 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c450t-eb92257a3f4026f9853a9d436e2aa8bb45e842c1264ff373ef6a5ea12c9b3e312 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/3482876 |
PMID | 22280204 |
ParticipantIDs | pubmed_primary_22280204 |
PublicationCentury | 2000 |
PublicationDate | 2012-10-01 |
PublicationDateYYYYMMDD | 2012-10-01 |
PublicationDate_xml | – month: 10 year: 2012 text: 2012-10-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | AIDS research and human retroviruses |
PublicationTitleAlternate | AIDS Res Hum Retroviruses |
PublicationYear | 2012 |
References | 18769358 - J Acquir Immune Defic Syndr. 2008 Oct 1;49(2):128-35 9841825 - J Infect Dis. 1999 Jan;179(1):74-82 15373913 - Clin Exp Immunol. 2004 Oct;138(1):116-21 18382686 - PLoS One. 2008;3(4):e1915 19098484 - AIDS. 2009 Jan 14;23(2):147-60 15728447 - J Immunol. 2005 Mar 1;174(5):2457-65 16034093 - J Immunol. 2005 Aug 1;175(3):1551-7 19690337 - Blood. 2009 Oct 29;114(18):3854-63 20521908 - Clin Infect Dis. 2010 Jul 15;51(2):242-7 17532476 - J Reprod Immunol. 2008 Jan;77(1):91-9 18184082 - AIDS Res Hum Retroviruses. 2007 Nov;23(11):1387-95 11160291 - J Immunol. 2001 Feb 15;166(4):2342-7 20719993 - J Gen Virol. 2010 Nov;91(Pt 11):2804-13 17048704 - Curr Top Microbiol Immunol. 2006;311:17-58 15718836 - AIDS. 2005 Feb 18;19(3):261-71 1280600 - FEBS Lett. 1992 Apr 13;301(1):23-8 15622449 - J Clin Immunol. 2004 Nov;24(6):647-52 17301562 - AIDS. 2007 Feb 19;21(4):441-6 11861616 - Annu Rev Immunol. 2002;20:709-60 19821521 - Hepatology. 2010 Jan;51(1):35-42 11561001 - J Exp Med. 2001 Sep 17;194(6):863-9 19265483 - J Infect Dis. 2009 Apr 15;199(8):1195-204 20113369 - Immunology. 2010 Jun;130(2):202-16 21425908 - Immunol Invest. 2011;40(5):498-522 15635478 - J Mol Med (Berl). 2005 Mar;83(3):180-92 20862220 - PLoS One. 2010;5(9). pii: e12831. doi: 10.1371/journal.pone.0012831 19769961 - Exp Mol Pathol. 2010 Feb;88(1):26-31 17997401 - Exp Mol Pathol. 2008 Feb;84(1):31-6 12776992 - Curr Mol Med. 2003 Jun;3(4):373-85 20610663 - Clin Vaccine Immunol. 2010 Sep;17(9):1417-27 20502346 - J Acquir Immune Defic Syndr. 2010 Jul;54(3):236-40 18031241 - Biochem Soc Trans. 2007 Dec;35(Pt 6):1437-44 19513613 - J Huazhong Univ Sci Technolog Med Sci. 2009 Jun;29(3):313-7 19945134 - Virology. 2010 Feb 5;397(1):34-42 17507480 - J Virol. 2007 Aug;81(15):8180-91 15241424 - Nature. 2004 Jul 8;430(6996):257-63 15622324 - AIDS. 2004 Dec 3;18(18):2437-9 17720662 - HIV Clin Trials. 2007 Jul-Aug;8(4):221-6 19109163 - J Immunol. 2009 Jan 1;182(1):319-28 12853962 - Nature. 2003 Jul 10;424(6945):213-9 18356597 - AIDS. 2008 Mar 30;22(6):685-94 19447460 - Virology. 2009 Jun 20;389(1-2):20-5 19855253 - AIDS. 2009 Nov 27;23(18):2387-95 11777946 - J Immunol. 2002 Jan 15;168(2):554-61 17084417 - Life Sci. 2007 Jan 2;80(4):307-13 20145198 - J Leukoc Biol. 2010 Jun;87(6):1133-43 17713639 - Biomedica. 2007 Jun;27(2):280-93 16224540 - J Clin Invest. 2005 Nov;115(11):3265-75 15307037 - Clin Infect Dis. 2004 Jul 15;39(2):264-9 19426550 - BMC Cell Biol. 2009;10:37 18334250 - Cell Immunol. 2007 Nov-Dec;250(1-2):75-84 19439987 - Intervirology. 2009;52(2):107-14 15539158 - Immunity. 2004 Nov;21(5):733-41 17360657 - Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3396-401 20147631 - J Immunol. 2010 Mar 15;184(6):2814-24 15034054 - J Immunol. 2004 Apr 1;172(7):4391-401 20479248 - Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10178-83 18556339 - Diabetes Care. 2008 Sep;31(9):1827-31 17907802 - PLoS Pathog. 2007 Sep 7;3(9):1281-90 21406030 - AIDS Res Hum Retroviruses. 2011 Oct;27(10):1099-109 19419540 - Retrovirology. 2009;6:42 19239434 - APMIS. 2009 Feb;117(2):124-32 19461969 - PLoS One. 2009;4(5):e5644 12734363 - J Immunol. 2003 May 15;170(10):5159-64 |
References_xml | – reference: 18356597 - AIDS. 2008 Mar 30;22(6):685-94 – reference: 19855253 - AIDS. 2009 Nov 27;23(18):2387-95 – reference: 19439987 - Intervirology. 2009;52(2):107-14 – reference: 20719993 - J Gen Virol. 2010 Nov;91(Pt 11):2804-13 – reference: 19447460 - Virology. 2009 Jun 20;389(1-2):20-5 – reference: 18334250 - Cell Immunol. 2007 Nov-Dec;250(1-2):75-84 – reference: 15307037 - Clin Infect Dis. 2004 Jul 15;39(2):264-9 – reference: 20521908 - Clin Infect Dis. 2010 Jul 15;51(2):242-7 – reference: 20145198 - J Leukoc Biol. 2010 Jun;87(6):1133-43 – reference: 15622324 - AIDS. 2004 Dec 3;18(18):2437-9 – reference: 12776992 - Curr Mol Med. 2003 Jun;3(4):373-85 – reference: 19109163 - J Immunol. 2009 Jan 1;182(1):319-28 – reference: 15034054 - J Immunol. 2004 Apr 1;172(7):4391-401 – reference: 11561001 - J Exp Med. 2001 Sep 17;194(6):863-9 – reference: 20113369 - Immunology. 2010 Jun;130(2):202-16 – reference: 18184082 - AIDS Res Hum Retroviruses. 2007 Nov;23(11):1387-95 – reference: 9841825 - J Infect Dis. 1999 Jan;179(1):74-82 – reference: 19098484 - AIDS. 2009 Jan 14;23(2):147-60 – reference: 19426550 - BMC Cell Biol. 2009;10:37 – reference: 15539158 - Immunity. 2004 Nov;21(5):733-41 – reference: 17907802 - PLoS Pathog. 2007 Sep 7;3(9):1281-90 – reference: 20862220 - PLoS One. 2010;5(9). pii: e12831. doi: 10.1371/journal.pone.0012831 – reference: 15635478 - J Mol Med (Berl). 2005 Mar;83(3):180-92 – reference: 21425908 - Immunol Invest. 2011;40(5):498-522 – reference: 12853962 - Nature. 2003 Jul 10;424(6945):213-9 – reference: 15728447 - J Immunol. 2005 Mar 1;174(5):2457-65 – reference: 19821521 - Hepatology. 2010 Jan;51(1):35-42 – reference: 19239434 - APMIS. 2009 Feb;117(2):124-32 – reference: 21406030 - AIDS Res Hum Retroviruses. 2011 Oct;27(10):1099-109 – reference: 18769358 - J Acquir Immune Defic Syndr. 2008 Oct 1;49(2):128-35 – reference: 17532476 - J Reprod Immunol. 2008 Jan;77(1):91-9 – reference: 15718836 - AIDS. 2005 Feb 18;19(3):261-71 – reference: 18031241 - Biochem Soc Trans. 2007 Dec;35(Pt 6):1437-44 – reference: 17301562 - AIDS. 2007 Feb 19;21(4):441-6 – reference: 19513613 - J Huazhong Univ Sci Technolog Med Sci. 2009 Jun;29(3):313-7 – reference: 19945134 - Virology. 2010 Feb 5;397(1):34-42 – reference: 19461969 - PLoS One. 2009;4(5):e5644 – reference: 17713639 - Biomedica. 2007 Jun;27(2):280-93 – reference: 20610663 - Clin Vaccine Immunol. 2010 Sep;17(9):1417-27 – reference: 16034093 - J Immunol. 2005 Aug 1;175(3):1551-7 – reference: 17048704 - Curr Top Microbiol Immunol. 2006;311:17-58 – reference: 15622449 - J Clin Immunol. 2004 Nov;24(6):647-52 – reference: 17997401 - Exp Mol Pathol. 2008 Feb;84(1):31-6 – reference: 18556339 - Diabetes Care. 2008 Sep;31(9):1827-31 – reference: 16224540 - J Clin Invest. 2005 Nov;115(11):3265-75 – reference: 15241424 - Nature. 2004 Jul 8;430(6996):257-63 – reference: 19419540 - Retrovirology. 2009;6:42 – reference: 1280600 - FEBS Lett. 1992 Apr 13;301(1):23-8 – reference: 20147631 - J Immunol. 2010 Mar 15;184(6):2814-24 – reference: 18382686 - PLoS One. 2008;3(4):e1915 – reference: 17084417 - Life Sci. 2007 Jan 2;80(4):307-13 – reference: 17507480 - J Virol. 2007 Aug;81(15):8180-91 – reference: 11861616 - Annu Rev Immunol. 2002;20:709-60 – reference: 19690337 - Blood. 2009 Oct 29;114(18):3854-63 – reference: 20502346 - J Acquir Immune Defic Syndr. 2010 Jul;54(3):236-40 – reference: 19769961 - Exp Mol Pathol. 2010 Feb;88(1):26-31 – reference: 17360657 - Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3396-401 – reference: 19265483 - J Infect Dis. 2009 Apr 15;199(8):1195-204 – reference: 12734363 - J Immunol. 2003 May 15;170(10):5159-64 – reference: 11777946 - J Immunol. 2002 Jan 15;168(2):554-61 – reference: 15373913 - Clin Exp Immunol. 2004 Oct;138(1):116-21 – reference: 11160291 - J Immunol. 2001 Feb 15;166(4):2342-7 – reference: 20479248 - Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10178-83 – reference: 17720662 - HIV Clin Trials. 2007 Jul-Aug;8(4):221-6 |
SSID | ssj0009225 |
Score | 2.266149 |
Snippet | Toll-like receptors (TLRs) play a critical role in innate immunity against pathogens. Their stimulation induces the activation of NF-κB, an important inducer... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 1313 |
SubjectTerms | Acquired Immunodeficiency Syndrome - genetics Acquired Immunodeficiency Syndrome - immunology Adolescent Adult CD4 Lymphocyte Count Dendritic Cells - immunology Female Flow Cytometry Gene Expression Regulation, Viral HIV-1 - metabolism Humans Immunity, Innate Macrophages - immunology Male Middle Aged RNA, Viral - metabolism Toll-Like Receptor 2 - genetics Toll-Like Receptor 2 - immunology Toll-Like Receptor 4 - genetics Toll-Like Receptor 4 - immunology Up-Regulation Viral Load Young Adult |
Title | HIV type 1 infection up-regulates TLR2 and TLR4 expression and function in vivo and in vitro |
URI | https://www.ncbi.nlm.nih.gov/pubmed/22280204 |
Volume | 28 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj9MwELa6ICEuiPcb-cCtMtSPtM5xBYvKinJgW2kPSCs7tUUkNi3ZpAd-Cz-WGdtJwwLicYksu47SzJfJzOSbGUKe58bmLvDCbGGYyteGWactk9oDmrW30mIccvF-Ol-p49PsdDT6NmAttY19UXz9ZV7J_0gV5kCumCX7D5LtTwoTMAb5whEkDMe_kvEcfLcQQ-U9qaoat1tWxwbz7mK8fPdBhO8DMFBYzj_SXiMDGd9pHddxV-42qRITjJt6M7RaD9--PhmnskAxEy629qtdgxGJur3YMxHnrq7C13feRaePW_jpPhgb2qilPK8FeOqbnhNkQm_Z8VEJmqWbXNVF-6UtGeixT-V5sHRPys-7tCuFK7joiW_wtokqNpecgVuZDXWw0EOsTQYalcuYq_qTqp9orJRqynWqwyoiz3cg9u15kDvGuDAF-M-rlypvd0sH5AB8EGyqipGgrqAzKMJUsxWu5OUP14EVptPeS95KsFqWN8mN5G7Qw4idW2Tkqtvk2iIRKu6QjwAhihCinPYQokMIUYQQBZnjQNE9hMJcByHYTBFCYTKMARl3yerN0fLVnKWGG6xQ2aRhzuK_mhnpFbjmPgdTzuRrJadOGKOtVZnTShQcjGjv5Uw6PzWZM1wUucVgurhHrlSbyj0glGtdgDcKxucanAZvjLATaWci8y5TzpqH5H68L2fbWFXlrLtjj3678phc3yPqCbnq4TF2T8EmbOyzIJzvZdpgTw |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=HIV+type+1+infection+up-regulates+TLR2+and+TLR4+expression+and+function+in+vivo+and+in+vitro&rft.jtitle=AIDS+research+and+human+retroviruses&rft.au=Hern%C3%A1ndez%2C+Juan+C&rft.au=Stevenson%2C+Mario&rft.au=Latz%2C+Eicke&rft.au=Urcuqui-Inchima%2C+Silvio&rft.date=2012-10-01&rft.eissn=1931-8405&rft.volume=28&rft.issue=10&rft.spage=1313&rft_id=info:doi/10.1089%2Faid.2011.0297&rft_id=info%3Apmid%2F22280204&rft_id=info%3Apmid%2F22280204&rft.externalDocID=22280204 |